- Home
- FNWD vs FHTX Comparison
FNWD vs FHTX Comparison
Compare FNWD & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNWD | FHTX |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | United States |
| Employees | N/A | 106 |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.1M | 213.8M |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FNWD | FHTX |
|---|---|---|
| Price | $42.45 | $3.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $37.50 | $11.50 |
| AVG Volume (30 Days) | 9.2K | ★ 412.7K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | ★ 25.32 |
| EPS | ★ 1.00 | N/A |
| Revenue | N/A | ★ $30,909,000.00 |
| Revenue This Year | $17.40 | $8.89 |
| Revenue Next Year | $5.44 | $20.13 |
| P/E Ratio | $43.24 | ★ N/A |
| Revenue Growth | N/A | ★ 36.75 |
| 52 Week Low | $30.05 | $3.27 |
| 52 Week High | $45.90 | $7.61 |
Technical Indicators
Market Signals| Indicator | FNWD | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 24.10 |
| Support Level | $42.56 | $3.57 |
| Resistance Level | $44.22 | $5.27 |
| Average True Range (ATR) | 0.68 | 0.22 |
| MACD | -0.09 | -0.08 |
| Stochastic Oscillator | 42.55 | 11.71 |
Price Performance
Historical ComparisonAbout FNWD Finward Bancorp
Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.